Mark L Ettenhofer

Summary

Publications

  1. pmc Reaction time variability in HIV-positive individuals
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, USA
    Arch Clin Neuropsychol 25:791-8. 2010
  2. pmc Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline
    Jessica M Foley
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA
    Appl Neuropsychol Adult 19:16-25. 2012
  3. pmc Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
    Neurology 74:1217-22. 2010
  4. pmc Aging, neurocognition, and medication adherence in HIV infection
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
    Am J Geriatr Psychiatry 17:281-90. 2009
  5. doi request reprint The significance of mild traumatic brain injury to cognition and self-reported symptoms in long-term recovery from injury
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
    J Clin Exp Neuropsychol 31:363-72. 2009

Detail Information

Publications5

  1. pmc Reaction time variability in HIV-positive individuals
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, USA
    Arch Clin Neuropsychol 25:791-8. 2010
    ..These preliminary findings suggest that measures of RT variability may provide enhanced sensitivity to neurocognitive disease burden in HIV/AIDS relative to more traditional measures of mean RT or cognitive function...
  2. pmc Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline
    Jessica M Foley
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, USA
    Appl Neuropsychol Adult 19:16-25. 2012
    ..Alongside younger age, factors contributing to cognitive reserve (i.e., education and estimated premorbid intelligence) may provide substantial benefit for older HIV-positive adults who are at high risk for NP compromise...
  3. pmc Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, CA, USA
    Neurology 74:1217-22. 2010
    ..However, little is known about the predictive pathways linking medication adherence with cognitive ability...
  4. pmc Aging, neurocognition, and medication adherence in HIV infection
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
    Am J Geriatr Psychiatry 17:281-90. 2009
    ..To evaluate the hypothesis that poor adherence to highly active antiretroviral treatment (HAART) would be more strongly related to cognitive impairment among older than among younger HIV-seropositive adults...
  5. doi request reprint The significance of mild traumatic brain injury to cognition and self-reported symptoms in long-term recovery from injury
    Mark L Ettenhofer
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
    J Clin Exp Neuropsychol 31:363-72. 2009
    ..50, p < .05). Results provide additional evidence that neurological injury in single-incident mild TBI is of little clinical significance to long-term cognitive and symptom outcome...